ADENTRA (TSE:ADEN) Reaches New 12-Month High – Still a Buy?

ADENTRA Inc. (TSE:ADENGet Free Report)’s share price reached a new 52-week high on Thursday . The stock traded as high as $39.81 and last traded at $39.75, with a volume of 43276 shares traded. The stock had previously closed at $39.04.

Analysts Set New Price Targets

Several research firms have commented on ADEN. Scotiabank lifted their target price on shares of ADENTRA from C$41.00 to C$46.00 in a research report on Thursday, January 29th. Raymond James Financial increased their price target on ADENTRA from C$43.00 to C$46.00 in a research report on Tuesday, November 11th. Stifel Nicolaus boosted their price objective on ADENTRA from C$47.00 to C$51.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. National Bank Financial raised their target price on ADENTRA from C$42.50 to C$54.50 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Finally, Canadian Imperial Bank of Commerce increased their price target on shares of ADENTRA from C$41.00 to C$42.00 in a research report on Tuesday, November 11th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

View Our Latest Analysis on ADENTRA

ADENTRA Trading Down 0.5%

The firm has a fifty day moving average of $36.04 and a two-hundred day moving average of $34.56. The company has a market cap of $967.95 million, a PE ratio of 22.71 and a beta of 1.56.

About ADENTRA

(Get Free Report)

Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.

Further Reading

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.